Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
„Sopharma” AD (the Company) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of June 3, 2022, „Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows:
– Number of shares subject to repurchase – 224,000 (two hundred twenty four thousand);
– Repurchase price – BGN 4.50 per share of the company’s capital;
– Repurchase date: June 13, 2022;
– Licensed investment intermediary who has been given the purchase order – „First Financial Brokerage House” D.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz
Informacja dystrybuowana przez: pap-mediaroom.pl
